Vimarsana
Biggest News Aggregation in the World

Page 2 - Multiplex Stocks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiplex Stocks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiplex Stocks Today - Breaking & Trending Today

Multiplex stocks: Hope trade sends PVR, Inox soaring; but will that story really play out? - Vimarsana News

Multiplex stocks: Hope trade sends PVR, Inox soaring; but will that story really play out?

Unlike hotels and resorts, where people will flock once again after vaccinations, Covid may have made a behavioural shift among cinema goers in favour of OTT platforms.

PVR, Inox Leisure hit seven-month low; tank up to 28% in a month - Vimarsana News

PVR, Inox Leisure hit seven-month low; tank up to 28% in a month

Shares of multiplex operators like PVR and Inox Leisure continued to remain under pressure, hitting seven-month lows on the BSE in intra-day trade on Friday after Delhi Chief Minister Arvind Kejriwal announced sweeping restrictions in a bid to break the chain of Covid-19 infections in the city. Among individual stocks, PVR slipped 3 per cent to Rs 1,030, while Inox Leisure dipped 2.5 per cent to Rs 248.45 on the BSE in intra-day trade today. Both these stocks are trading at their lowest level since September 2020. In the past one month, PVR (down 28%) and Inox Leisure (down 25.2%) have underp...

Despite Q3 loss, analysts still bullish on this multiplex stock & why! - Vimarsana News

Despite Q3 loss, analysts still bullish on this multiplex stock & why!

After a 107 per cent surge from its 52-week lows of Rs 712, touched on May 7, 2020, analysts believe there is further upside left in the stock of multiplex owner PVR even as the firm posted a Q3 net loss of Rs 49 crore. Most brokerages maintained their bullish view on the company post its December quarter numbers, projecting an upside of up to 25 per cent in the stock from its current market price of around Rs 1,475, led by good management of costs and liquidity, and expectations of strong bounceback in footfalls. The rollout of Covid-19 vaccine also bodes well for the company, analysts bel...